molnupiravir bill will end the pandemic early 2022
molnupiravir bill will end the pandemic early 2022
|
Oct 15 2021, 06:55 PM, updated 3y ago
Show posts by this member only | Post
#1
|
Senior Member
3,772 posts Joined: May 2016 |
https://www.nature.com/articles/d41586-021-02783-1 https://www.forbes.com/sites/williamhaselti...sh=16f9042c1200 Good news at last!!! Can’t wait! Retweet: The World Health Organization (WHO) recently gave an end date for the epidemic: "The pandemic will end in early 2022." Zhang Wenhong also said that the end is not far away. And the wonder drug was born. The drug translates as Monapinavir, Developed by Germany's Rigibel and America's Merck, Phase I and phase II clinical trials have been successfully completed in humans with 100% efficacy. Phase 3 clinical trials are nearing completion and the results are excellent. If successful, in 4 to 5 months can be launched. The drug can be taken orally at home and recovered in 5 days. It is very convenient to use. Treating the new coronavirus later is like treating the common cold now. The drug was originally developed for the flu virus. It's a compound that blocks the viral IA enzyme, which prevents the virus from replicating itself, and essentially destroys the virus very quickly. The current principle of the vaccine against the new coronavirus is to target the new corona virus's rim, thereby preventing the virus from binding to human cells. The principles are different. In March and April last year, mink farms in Holland and Norway were infected with new coronavirus, resulting in millions of mink mass deaths. The farm fed the mink with Monapinavir. After 24 hours, no new coronavirus was found in the sick minks, and the farm stopped the transmission of the new virus. Then the two major pharmaceutical companies on the human body to carry out the first phase of clinical trials, after the success of the second phase, the third phase clinical trial, so far is about to officially launch. All in all, this is a great achievement for the scientific community, especially the medical community. It may be the fourth classic after valium, aspirin and penicillin. Developed by Japan's powerful Shiono Yoshi Corporation and Hokkaido University, the new crown drug will be put into production in December, Direct oral once a day, five days cure, very cheap and very safe, has just entered the third phase of clinical trials, the epidemic will eventually end. |
|
|
|
Oct 15 2021, 07:03 PM
Show posts by this member only | Post
#2
|
Junior Member
755 posts Joined: Mar 2010 |
another copy paste without checking, no mink farm fed their minks with molnupiravir/Monapinavir
currently this drug still clinical trial in lab only |
|
Oct 15 2021, 07:27 PM
Show posts by this member only | Post
#3
|
Junior Member
377 posts Joined: Jun 2016 |
Expensive
|
|
Oct 16 2021, 03:54 AM
Show posts by this member only | Post
#4
|
Senior Member
6,427 posts Joined: Jan 2003 From: Autobiography!!! |
QUOTE(Ckmwpy0370 @ Oct 15 2021, 06:55 PM) https://www.nature.com/articles/d41586-021-02783-1 1st ly fake news from CCP as there is spelling errors all around https://www.forbes.com/sites/williamhaselti...sh=16f9042c1200 Good news at last!!! Can’t wait! Retweet: The World Health Organization (WHO) recently gave an end date for the epidemic: "The pandemic will end in early 2022." Zhang Wenhong also said that the end is not far away. And the wonder drug was born. The drug translates as Monapinavir, Developed by Germany's Rigibel and America's Merck, Phase I and phase II clinical trials have been successfully completed in humans with 100% efficacy. Phase 3 clinical trials are nearing completion and the results are excellent. If successful, in 4 to 5 months can be launched. The drug can be taken orally at home and recovered in 5 days. It is very convenient to use. Treating the new coronavirus later is like treating the common cold now. The drug was originally developed for the flu virus. It's a compound that blocks the viral IA enzyme, which prevents the virus from replicating itself, and essentially destroys the virus very quickly. The current principle of the vaccine against the new coronavirus is to target the new corona virus's rim, thereby preventing the virus from binding to human cells. The principles are different. In March and April last year, mink farms in Holland and Norway were infected with new coronavirus, resulting in millions of mink mass deaths. The farm fed the mink with Monapinavir. After 24 hours, no new coronavirus was found in the sick minks, and the farm stopped the transmission of the new virus. Then the two major pharmaceutical companies on the human body to carry out the first phase of clinical trials, after the success of the second phase, the third phase clinical trial, so far is about to officially launch. All in all, this is a great achievement for the scientific community, especially the medical community. It may be the fourth classic after valium, aspirin and penicillin. Developed by Japan's powerful Shiono Yoshi Corporation and Hokkaido University, the new crown drug will be put into production in December, Direct oral once a day, five days cure, very cheap and very safe, has just entered the third phase of clinical trials, the epidemic will eventually end. 2nd the drug is from Ridgeback Pharma which is based in Florida |
|
Oct 16 2021, 09:58 AM
Show posts by this member only | IPv6 | Post
#5
|
Senior Member
4,490 posts Joined: Oct 2014 |
I had said it and I will say it again. It's a serious conflict of interest when Merck who made both Ivermectin and Molnupiravir telling everyone not to consume Ivermectin and months later issuing press release claiming Molnupiravir work at reducing death without publishing data. tertiary liked this post
|
|
Oct 16 2021, 10:07 AM
Show posts by this member only | IPv6 | Post
#6
|
Senior Member
2,638 posts Joined: Jul 2005 From: Bestine, the capital of Tatooine |
QUOTE(jmas @ Oct 15 2021, 07:03 PM) another copy paste without checking, no mink farm fed their minks with molnupiravir/Monapinavir They give the mink ivermectin. Molnupiravir actually just ivermectin with new name and probably with a higher price tag. The way its work actually very similar to ivermectin.currently this drug still clinical trial in lab only |
|
Oct 16 2021, 04:53 PM
Show posts by this member only | IPv6 | Post
#7
|
Junior Member
755 posts Joined: Mar 2010 |
QUOTE(blackamikaze @ Oct 16 2021, 10:07 AM) They give the mink ivermectin. Molnupiravir actually just ivermectin with new name and probably with a higher price tag. The way its work actually very similar to ivermectin. again, fact checkQUOTE QUOTE The two drugs have “dissimilar chemistry,” he said. “There is no way that Merck is doing this,” he said. “Molnupiravir is a derivative of a nucleotide that, predictably, interferes with the RNA replication of the virus. While Ivermectin does also have a defined mechanism of action, BUT it’s against ion channels found in parasites,” Griffin said. QUOTE “Ivermectin is classified as a macrocyclic lactone. It is derived from Streptomyces avermitilis which is a bacterium." Molnupiravir, rather, is classified as a nucleoside analog (like some HIV medications) and works as an antiviral from Reuters one (Ivermectin) against parasite, another (Molnupiravir) against virus |
Change to: | 0.0111sec
0.43
5 queries
GZIP Disabled
Time is now: 28th March 2024 - 09:09 PM |